Pharmaco-ethnicity and its Impact on Prostate Cancer Treatment - Darren MC Poon
Darren Poon
Darren Poon joins Alicia Morgans to discuss his presentation on pharmaco-ethnicities specifically as it relates to drug toxicities in Asian patients, and why it is important to think about on a wider scale at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC).
PROfound Study - PARP-inhibitor Olaparib in Advanced Prostate Cancer Patients with Specific Tumor Mutations - Maha Hussain
Maha Hussain
Maha Hussain joins Alicia Morgans sharing an overview of the PROfound study design, it's intent, and specifications on how it was designed to arrive at the answer it was seeking.